Seizures associated with quetiapine treatment

被引:21
作者
Dogu, O [1 ]
Sevim, S [1 ]
Kaleagasi, HS [1 ]
机构
[1] Mersin Univ Hastanesi, Dept Neurol, Fac Med, TR-33070 Mersin, Turkey
关键词
Alzheimer disease; quetiapine; seizure;
D O I
10.1345/aph.1C516
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To report a case of seizures in a patient with Alzheimer disease, who was receiving quetiapine for psychoses. CASE SUMMARY: A 75-year-old white man with Alzheimer disease was observed to have seizures while receiving quetiapine 500 mg/d and carbamazepine 200 mg/d. He had been taking quetiapine for 18 months prior to the event. No other toxic, metabolic, or anatomic abnormalities were identified to explain the seizures. After cessation of quetiapine treatment, the patient remained seizure free. An objective causality assessment revealed that the adverse drug reaction was possible. DISCUSSION: The patient was taking a relatively high dose of quetiapine. An increased risk of seizures has been associated with Alzheimer disease. Using a relatively high dose of quetiapine may have resulted in seizures in our patient with Alzheimer disease. CONCLUSIONS: As with other antipsychotics, quetiapine should be used cautiously in elderly patients with conditions that can lower the seizure threshold, and special monitoring should be performed for this serious adverse effect.
引用
收藏
页码:1224 / 1227
页数:4
相关论文
共 24 条
[1]  
Arvanitis L, 1999, NEUROLOGY, V52, pA398
[2]   Multiple fixed doses of ''Seroquel'' (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo [J].
Arvanitis, LA ;
Miller, BG ;
Borison, RL ;
Pitts, WM ;
Sharif, ZA ;
Hamner, MB ;
Herz, MI ;
True, JE ;
Velligan, D ;
Knesevich, MA ;
Small, J ;
Steinbook, R ;
Hertzman, M ;
Keck, PE ;
Newcomer, JW ;
Grace, J ;
Rotrosen, J ;
Tandon, R ;
Dott, SG ;
Ferguson, JM ;
Addington, DEN ;
MacEwan, GW ;
Nair, VNP ;
Shriqui, CL ;
Williams, R ;
Daniel, DG ;
Shehi, GM ;
Patterson, WM ;
Merideth, CH .
BIOLOGICAL PSYCHIATRY, 1997, 42 (04) :233-246
[3]   Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial [J].
Beasley, CM ;
Tollefson, G ;
Tran, P ;
Satterlee, W ;
Sanger, T ;
Hamilton, S ;
Fabre, L ;
Small, J ;
Ereshefsky, L ;
True, J ;
Nemeroff, C ;
Risch, SC ;
Perry, PJ ;
Potkin, SG ;
Borison, RL ;
James, S ;
Meltzer, HY ;
Iqbal, N ;
Fann, WE ;
Gewirtz, GR ;
Landbloom, R ;
RoyByrne, PP ;
Tuason, VB ;
Carman, JS ;
Stokes, PE ;
Williams, R ;
Ancill, RJ ;
MacEwan, GW ;
Gujavarty, KS ;
Jones, B ;
Lohr, JB .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :111-123
[4]   Quetiapine - A review of its safety in the management of schizophrenia [J].
Dev, V ;
Raniwalla, J .
DRUG SAFETY, 2000, 23 (04) :295-307
[5]   CLOZAPINE-RELATED SEIZURES [J].
DEVINSKY, O ;
HONIGFELD, G ;
PATIN, J .
NEUROLOGY, 1991, 41 (03) :369-371
[6]  
EMERSON RG, 1999, NEUROLOGY CLIN PRACT, V1, P473
[7]   Elevation of carbamazepine-10,11-epoxide by quetiapine [J].
Fitzgerald, BJ ;
Okos, AJ .
PHARMACOTHERAPY, 2002, 22 (11) :1500-1503
[8]   Focus on quetiapine [J].
Green, B .
CURRENT MEDICAL RESEARCH AND OPINION, 1999, 15 (03) :145-151
[9]   New-onset seizure associated with quetiapine and olanzapine [J].
Hedges, DW ;
Jeppson, KG .
ANNALS OF PHARMACOTHERAPY, 2002, 36 (03) :437-439
[10]   Dementia and adult-onset unprovoked seizures [J].
Hesdorffer, DC ;
Hauser, WA ;
Annegers, JF ;
Kokmen, E ;
Rocca, WA .
NEUROLOGY, 1996, 46 (03) :727-730